NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer

J Hilli, L Sailas, S Jyrkkiö, S Pyrhönen, K Laine

Research output: Contribution to journal › Article › Scientific › peer-review

10 Citations (Scopus)

Original language	English
Pages (from-to)	1353-1362
Journal	CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume	67
Issue number	6
Publication status	Published - 2011
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{54a449580a764082b93129c0a0014740,

title = "NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer",

author = "J Hilli and L Sailas and S Jyrkki{\"o} and S Pyrh{\"o}nen and K Laine",

year = "2011",

language = "English",

volume = "67",

pages = "1353--1362",

journal = "CANCER CHEMOTHERAPY AND PHARMACOLOGY",

issn = "0344-5704",

publisher = "Springer Verlag",

number = "6",

}

TY - JOUR

T1 - NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer

AU - Hilli, J

AU - Sailas, L

AU - Jyrkkiö, S

AU - Pyrhönen, S

AU - Laine, K

PY - 2011

Y1 - 2011

M3 - Article

SN - 0344-5704

VL - 67

SP - 1353

EP - 1362

JO - CANCER CHEMOTHERAPY AND PHARMACOLOGY

JF - CANCER CHEMOTHERAPY AND PHARMACOLOGY

IS - 6

ER -